🇬🇧 Sandostatin in United Kingdom

Sandostatin (OCTREOTIDE) regulatory status in United Kingdom.

Marketing authorisation

MHRA

  • Status: likely_approved

Sandostatin in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Oncology approved in United Kingdom

Frequently asked questions

Is Sandostatin approved in United Kingdom?

Yes. MHRA has authorised it.

Who is the marketing authorisation holder for Sandostatin in United Kingdom?

Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.